Vanguard Group’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$185M Sell
12,477,780
-94,378
-0.8% -$1.33M ﹤0.01% 1581
2025
Q3
$161M Sell
12,572,158
-354,804
-3% -$4.73M ﹤0.01% 1658
2025
Q2
$196M Sell
12,926,962
-389,107
-3% -$6.07M ﹤0.01% 1506
2025
Q1
$222M Buy
13,316,069
+603,079
+5% +$11.1M ﹤0.01% 1435
2024
Q4
$240M Sell
12,712,990
-10,638,760
-46% -$205M ﹤0.01% 1460
2024
Q3
$439M Sell
23,351,750
-551,720
-2% -$10.6M 0.01% 1119
2024
Q2
$452M Sell
23,903,470
-220,616
-0.9% -$3.76M 0.01% 1043
2024
Q1
$392M Buy
24,124,086
+1,206,573
+5% +$17.7M 0.01% 1130
2023
Q4
$290M Buy
22,917,513
+635,672
+3% +$8.02M 0.01% 1308
2023
Q3
$303M Buy
22,281,841
+119,477
+0.5% +$1.84M 0.01% 1197
2023
Q2
$380M Sell
22,162,364
-225,480
-1% -$3.49M 0.01% 1092
2023
Q1
$312M Buy
22,387,844
+257,661
+1% +$3.79M 0.01% 1181
2022
Q4
$296M Buy
22,130,183
+443,938
+2% +$5.74M 0.01% 1190
2022
Q3
$258M Sell
21,686,245
-704,713
-3% -$10M 0.01% 1236
2022
Q2
$285M Sell
22,390,958
-1,476,701
-6% -$19M 0.01% 1202
2022
Q1
$309M Buy
23,867,659
+134,239
+0.6% +$1.77M 0.01% 1279
2021
Q4
$376M Buy
23,733,420
+417,364
+2% +$7.12M 0.01% 1180
2021
Q3
$454M Buy
23,316,056
+369,612
+2% +$7.34M 0.01% 1034
2021
Q2
$522M Buy
22,946,444
+1,196,798
+6% +$24.8M 0.01% 965
2021
Q1
$400M Sell
21,749,646
-225,437
-1% -$3.7M 0.01% 1093
2020
Q4
$327M Buy
21,975,083
+555,644
+3% +$7.25M 0.01% 1132
2020
Q3
$240M Sell
21,419,439
-541,789
-2% -$5.33M 0.01% 1161
2020
Q2
$174M Sell
21,961,228
-328,922
-1% -$2.72M 0.01% 1354
2020
Q1
$180M Buy
22,290,150
+729,568
+3% +$8.67M 0.01% 1193
2019
Q4
$271M Sell
21,560,582
-77,789
-0.4% -$838K 0.01% 1204
2019
Q3
$193M Buy
21,638,371
+157,326
+0.7% +$1.38M 0.01% 1350
2019
Q2
$184M Buy
21,481,045
+9,475
+0% +$74.9K 0.01% 1414
2019
Q1
$163M Buy
21,471,570
+417,852
+2% +$3.36M 0.01% 1465
2018
Q4
$174M Buy
21,053,718
+1,538,106
+8% +$14.7M 0.01% 1326
2018
Q3
$193M Buy
19,515,612
+144,048
+0.7% +$1.49M 0.01% 1413
2018
Q2
$189M Buy
19,371,564
+34,754
+0.2% +$341K 0.01% 1385
2018
Q1
$180M Buy
19,336,810
+1,395,044
+8% +$13.3M 0.01% 1353
2017
Q4
$171M Sell
17,941,766
-586,173
-3% -$5.6M 0.01% 1406
2017
Q3
$192M Buy
18,527,939
+98,191
+0.5% +$907K 0.01% 1292
2017
Q2
$152M Buy
18,429,748
+684,946
+4% +$5.14M 0.01% 1417
2017
Q1
$128M Buy
17,744,802
+981,382
+6% +$7.11M 0.01% 1519
2016
Q4
$120M Buy
16,763,420
+634,299
+4% +$4.41M 0.01% 1510
2016
Q3
$117M Buy
16,129,121
+574,623
+4% +$3.65M 0.01% 1461
2016
Q2
$91.1M Buy
15,554,498
+384,126
+3% +$2.54M 0.01% 1579
2016
Q1
$96.5M Buy
15,170,372
+737,852
+5% +$3.96M 0.01% 1507
2015
Q4
$92.6M Buy
14,432,520
+894,514
+7% +$5.59M 0.01% 1524
2015
Q3
$78.7M Buy
13,538,006
+63,949
+0.5% +$474K 0.01% 1606
2015
Q2
$118M Buy
13,474,057
+889,288
+7% +$7.47M 0.01% 1411
2015
Q1
$101M Buy
12,584,769
+500,696
+4% +$3.74M 0.01% 1492
2014
Q4
$93.8M Buy
12,084,073
+929,717
+8% +$6.78M 0.01% 1467
2014
Q3
$72.3M Buy
11,154,356
+1,410,135
+14% +$10.9M 0.01% 1583
2014
Q2
$81.9M Buy
9,744,221
+772,530
+9% +$5.99M 0.01% 1537
2014
Q1
$60.2M Buy
8,971,691
+1,277,287
+17% +$7.74M 0.01% 1704
2013
Q4
$48.1M Buy
7,694,404
+621,847
+9% +$3.04M ﹤0.01% 1806
2013
Q3
$30.8M Buy
7,072,557
+556,186
+9% +$2.54M ﹤0.01% 1958
2013
Q2
$28.8M Buy
+6,516,371
New +$28.9M ﹤0.01% 1929

Other funds holding SEM

Vanguard Group's SEM Position: Q4 2025 in Review

Vanguard Group reduced its Select Medical (SEM) stake by 0.75% in Q4 2025, selling an estimated $1.33M and leaving 12,477,780 shares worth $185M. The position accounts for ﹤0.01% of the portfolio, ranked #1581.

Vanguard Group first reported a position in SEM in Q2 2013 and has held it in 51 quarters since. The position peaked at $522M in Q2 2021. 268 funds tracked by Wall St. Rank hold SEM as of Q4 2025.

  • Vanguard Group held 12,477,780 shares of Select Medical worth $185M as of Q4 2025.
  • Vanguard Group sold 94,378 Select Medical shares in Q4 2025, an estimated $1.33M.
  • Select Medical made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1581 holding.
  • Vanguard Group first reported a position in Select Medical in Q2 2013 and has held it in 51 quarters since.
  • Vanguard Group's Select Medical position peaked at $522M in Q2 2021.
  • 268 funds tracked by Wall St. Rank held Select Medical as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.